Acute kidney injury (AKI) signifies frequent complication after cardiac surgery using cardiopulmonary bypass (CPB) 
INTRODUCTION
Worldwide, more than 2 million cardiac surgeries are performed annually. Cardiac surgeryassociated acute kidney injury (CSA-AKI) is a candid postoperative complexity and is the second most frequent cause of AKI in the intensive care unit (Hilde R. H. de Geus et al, 2016 ). An incidence of CSA-AKI of up to 39% has been declared, varying depending on patient-related baseline characteristics and the type of surgery (Mao H et al, 2013). Between 3% and 6.5% all of surgical patients demand renal replacement medication. This worst stage of CSA-AKI is independently related with a very high mortality rate (Wald R et al, 2015). Other clinical consequences of CSA-AKI are represented in prolonged hospital stay, increased risk of chronic kidney disease (CKD), and increased risk of death after surgery (Hansen MK, 2013).
In current clinical practice, the gold standard for determination and categorization of AKI relies upon serial measurements of serum creatinine (Valerie Au et al, 2016). Unfortunately, Serum creatinine measurements are particularly unreliable during acute changes in kidney function as it has many inherent limitations (Jo SK et al, 2007). First, serum creatinine concentrations might not change until permanently 50% of kidney function has been lost. Second, serum creatinine does not properly reflect kidney function until a steady state has been reached, which could take several days. Finally, the serum levels of creatinine are affected by several non-renal factors such as age, gender, race, and muscular mass as well as factors such as drug metabolism, protein intake, perioperative fluid administration and hydration status (CR Parikh et al, 2006). All these reasons contribute to significant retards in the diagnosis of AKI.
As a result ofthe delayed response of creatinine and the deficiency of specific symptoms, AKI is often diagnosed late as well as an early specific therapy of intrinsic acute kidney injury is usually unavailable. On the other hand, creatinine often reflects chronic kidney disease rather than acute kidney injury. Because of these shortcomings of serum creatinine, more reliable biomarkers are needed for the diagnosis of acute kidney injury and provide prognostic information on outcomes once AKI is established (Siew et al, 2011). A desirable biomarker should be non-invasive, detectable at very early stages of 
MATERIALS AND METHODS
This study was carried out as a cross-sectional study in Pediatric cardio surgery Academy, Ain Shams University hospital, it included 30 children patients who were suffering from congenital heart disease and undergoing cardiac surgery with cardiopulmonary bypass during the period from March 2015 to July 2015. All participants gave their informed written consent. The study populations ranging in age from 1 weak to 204 months, 19 of them were males and 11 were females. Two ml of blood samples were collected before surgery were used as the baseline, further sampling occurred at CPB termination, 2 hours after CPB, on the first and second day after surgery. Creatinine and blood urea were analyzed using automated assay based on modified kinetic Jaffe reaction (Chemistry analyzer BTS-310 from biosystems, Co. EU). Ten ml urine samples, for measurement of lipocalin, were collected before surgery were used as the baseline, further sampling occurred at CPB termination, 2 hours after CPB, and on the first day after surgery. Urinary lipocalin biomarker measurement was performed using ELISA kit (Glory Science Co., Ltd: 2400 Veterans Blvd. Suite 16 -101, Del Rio, TX 78840, USA) with 0.3μg/L -7μg/L detection range.
Statistical analysis:
Statistical analysis was performed using Statistical Program for Social Science (SPSS) version 20.0. Quantitative data were expressed as the mean± standard deviation (SD). Qualitative data were expressed as frequency and percentage. Independent-samples t-test of significance was used when comparing two means. Paired sample t-test of significance was used when comparing between related samples. Chi-square (X2) test of significance was used in order to compare proportions between two qualitative parameters. Receiver operating characteristic (ROC curve) analysis was used to find out the overall predictively of a parameter and to find out the best cut-off value with detection of sensitivity and specificity at this cut-off value.
RESULTS
Descriptive and comparative statistics of the demographic and laboratory data among AKI group and non-AKI group are included in table1.
The AKI group conducted into 9 patients while the non-AKI group conducted into 21 patients. There were 21 (70%) children with Cyanotic congenital heart disease and 9 (30%) children with acyanotic congenital heart disease. A significant increase in creatinine and blood urea in AKI group was delayed to the second day after CPB while, lipocalin increased significantly within 2 hours after surgery. Performanceof AKI markers that used in the present study are illustrated in table 2. Receiver operating characteristic (ROC) curve of serum creatinine levels at different time points after CPB are presented in figure 1 . In this study, the ROC analysis showed the excellent diagnostic power of urinary lipocalin at 2 h post-CPB in predicting the future onset of AKI figure 2.
A significant association was found between urinary lipocalin at 2 hours and 24 hours after surgery and CPB time, operation time and hospital stay (Table 3) . Furthermore, there were statistically significant correlations between urinary lipocalin at 2 hours and 24 hours post-surgery with the type of congenital heart defect ( Table  4) . Also, there were statistically significant correlations between urinary lipocalin at 2 hours and 24 hours post-surgery with death ( In our study creatinine was measured at different time intervals; 2 hours postoperative, 24 hours postoperative and 48 hours postoperative. This work was done to observe the performance of creatinine throughout two days after surgery. Serum creatinine was in normal range in all patients throughout 24 hours postoperative and shows a significant increase in AKI patients only 48 hours postoperative. That means, by using creatinine alone, AKI can only be detected 48 hours postoperative.
Comparing AKI group and non-AKI group, there was no statistically significant difference in creatinine level at 2 hours postoperative. Our results were comparable to the study done by Vishal Jain et al. (2016) where they found no statistically significant difference in creatinine level 2 hours postoperative.
In this study there was no statistically significant difference in creatinine level 24 hours postoperative Also, the study that was done by Elena Bignami et al (2015) on 19 patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) demonstrated that there was no statistically significant difference between AKI and non-AKI patients according to SCr level 24 hours postoperative.
This study showed that SCr levels in AKI group 48 h post-operative ranged from 1.5-1.9 mg/dl with a mean of 1.67±0.16 mg/dl, while. S.cr levels in non-AKI group 48 h post-operative ranged from 0.5-0.9 mg/dl with a mean of 0.64±0.11 mg/dl. A highly significant difference was noted between the two groups regarding SCr at 48 h post operation. The increase in serum creatinine was delayed by 2 days after CPB suggesting the presence of intrinsic AKI rather than a prerenal etiology.
Similar results were documented in the study done by Michael Bennett et al. (2008) . They found a highly significant difference between the two groups with respect to Serum creatinine 48 hours (mg/dl).
In the current study lipocalin levels increased in AKI patients very soon (2hours) after the procedure, and remained significantly elevated up to 24 h after the operation. Michael Bennett et al. (2008) showed similar findings of statistical significant of lipocalin measurement at 24 h after surgery like this current study results.
Biomarkers have a good discriminatory value if the AUC is greater than 75 % and an excellent discriminatory value if the AUC is greater than 90 % (Avinash B. Kumar and Manish Suneja, 2011). In this study, the ROC analysis showed the excellent diagnostic power of urinary lipocalin at 2 hours post-CPB in predicting the future onset of AKI (Table 3 & figure 2 ). This finding was similar to the study of AmiraPeco-Antić et al. (2013) to assess the utility of urine lipocalin as a predictor of AKI and after weighting the AUCs, the timing of measurement, and the p values from the predictive logistic model they selected urine lipocalin as the perfect AKI predictor at 6 hours and 24 hours post-surgery. At 6 and 24 h after CPB the AUC was found for urine lipocalin to be (0.70 and 0.93, respectively). This study revealed that there was a strong significant direct correlation between urinary lipocalin and bypass time at 2 hours and 24 hours after surgery.Similar results were documented in the study that done by Catherine D et al. (2011) . Their study showed that there was a strong significant direct correlation between urinary lipocalin and bypass time at 6 hours and 12 hours after surgery.
In the present study, age was significantly lower in children who developed AKI than in those who did not. This finding was in accordance with Mischel and Paulo (2013). Moreover, this study demonstrated that patients with cyanotic heart disease are more common to develop AKI after cardiopulmonary bypass surgery. In the present study, a significant correlation was found between urine lipocalin levels at 2 hours and 24 hours after CPB surgery and death. Similar results were noted in the study that done by Bennett et al. (2008) on children undergoing CPB surgery. They found that elevated urine lipocalin levels correlated with mortality.
From this study, it could be concluded that AKI is common after pediatric CPB surgery and associated with poor outcomes. This study demonstrated that urinary lipocalin levels rose significantly in patients fulfilling the criteria for AKI much earlier as compared to serum creatinine in early hours after surgery. Such finding reflects the clinical utility of lipocalin for prediction AKI. Clinicians informed of such a situation would be aware of the potential for development of clinical AKI.The ability to predict which patients will develop AKI after CPB could enable early initiation of interventions to change the dismal outcomes associated with this all-toocommon clinical problem.
